All In Biotech

Drug Trial Radar · NCT01914393

Pediatric Open-Label Extension Study

A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects

Last checked: Nov 20, 2026Latest source record: Dec 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

702

Actual

Start

Sep 30, 2013

Primary completion

Oct 17, 2018

Study completion Oct 17, 2018

Sponsor

Lead sponsor
Sumitomo Pharma America, Inc.Industry
Sponsor type
Industry
First posted
Aug 2, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, 104-week, multicenter, extension study designed to evaluate the long-term safety, tolerability and effectiveness of flexibly dosed lurasidone (20, 40, 60 or 80 mg/day) in pediatric subjects who have completed the 6-week treatment period in the preceding studies, D1050301, D1050325, and D1050326

Conditions

  • Schizophrenia
  • Autism
  • Bipolar Depression

Interventions

  • Lurasidone 20, 40, 60, 80 mg, flexibly dosedDrug

    Lurasidone 20, 40, 60, 80 mg once daily, flexibly dosed

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Subjects With Adverse Events (AEs), Discontinuations Due to AEs and Serious AEs (SAEs)Time frame: During 104 Weeks (2-years) treatment period

Locations

88 sites in 15 countries. Site status is shown where the registry gives one.

  • Harmonex Neuroscience Research

    Dothan, Alabama

  • Diligent Clinical Trials, Inc

    Downey, California

  • University of California San Francisco Medical Center

    San Francisco, California

  • Neuropsychiatric Research Center of Orange County

    Santa Ana, California

  • Sarkis Clinical Trials - Parent

    Gainesville, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • APG Research, LLC

    Orlando, Florida

  • Medical Research Group of Central Florida

    Sanford, Florida

  • University of South Florida

    St. Petersburg, Florida

  • University of South Florida Rothman Center of Neuropychiatry

    Tampa, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Attalla Consultants, LLC

    Smyrna, Georgia

  • Psychiatric Associates

    Overland Park, Kansas

  • University Of Kentucky

    Lexington, Kentucky

  • Lake Charles Clinical Trials LLC,2770 3rd Avenue,Suite 340

    Lake Charles, Louisiana

  • Kennedy Krieger Institute

    Baltimore, Maryland

  • Neurobehavioral medicine Group, LLC

    Bloomfield Hills, Michigan

  • St. Charles Psychiatric Associates

    Saint Charles, Missouri

  • Jersey Shore University Medical Center

    Neptune City, New Jersey

  • North Shore/Long Island Jewish PRIME

    Glen Oaks, New York

  • Dr. Jeanette Cueva

    Mount Kisco, New York

  • Montefiore Medical Center PRIME

    New York, New York

  • Finger Lakes Clinical Research

    Rochester, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • The Ohio State University Nisonger Center

    Columbus, Ohio

  • Cutting Edge Research Group

    Oklahoma City, Oklahoma

  • Pillar Clinical Research, LLC

    Dallas, Texas

  • Family Psychiatry of The Woodlands, P.A.

    The Woodlands, Texas

  • Ericksen Research & Development, LLC

    Clinton, Utah

  • University of Virginia

    Charlottesville, Virginia

  • Neuroscience, Inc.

    Herndon, Virginia

  • Clinical Research Partners, LLC

    Petersburg, Virginia

  • Carilion Clinic

    Roanoke, Virginia

  • MHC - Ruse, EOOD

    Rousse, Bulgaria

  • UMHAT "Alexandrovska" EAD

    Sofia, Bulgaria

  • MHAT-Targovishte, AD

    Targovishte, Bulgaria

  • DCC "Mladost M" - Varna, OOD

    Varna, Bulgaria

  • Centro de Investigaciones y Proyectos en Neurociencias CIPNA

    Barranquilla, Colombia

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.